Zoetis (ZTS) EBIT Margin (2012 - 2026)

Zoetis (ZTS) reported EBIT Margin of 36.83% for Q1 2026, down 157.0% year-over-year from 64.61% in Q1 2025, and up 4.52% quarter-over-quarter from 35.23% in Q4 2025.

Zoetis (ZTS) EBIT Margin (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of EBIT Margin data on file, last reported at 36.83% in Q1 2026.

  • EBIT Margin for Q1 2026 came in at 36.83%, down 157.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 38.49% (up 63.0% YoY), and the FY2025 annual result was 38.83%, up 112.0% from the prior year.
  • EBIT Margin advanced to 36.83% in Q1 2026 per ZTS's latest filing, from 35.23% in the prior quarter.
  • Over five years, EBIT Margin peaked at 41.69% in Q1 2022 and troughed at 33.66% in Q4 2023.
  • A 5-year average of 37.86% and a median of 37.76% in 2024 frame the typical range for EBIT Margin.
  • The sharpest annual moves came in 2022 and 2023: EBIT Margin soared 4864 bps in 2022, then slumped 449 bps in 2023.
  • A 5-year view of EBIT Margin shows it stood at 35.69% in 2022, then slipped by 6 bps to 33.66% in 2023, then increased by 3 bps to 34.61% in 2024, then increased by 2 bps to 35.23% in 2025, then rose by 5 bps to 36.83% in 2026.
  • Business Quant data shows ZTS's EBIT Margin at 36.83% in Q1 2026, 35.23% in Q4 2025, and 40.17% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 16.37%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 36.83%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 41.69%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 20.77%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 23.74%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 22.39%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -122.23%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 21.55%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -12.88%
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 46.29%

Historic Data

Download Data
DateValue
Mar 31, 2026 36.83%
Dec 31, 2025 35.23%
Sep 30, 2025 40.17%
Jun 30, 2025 41.54%
Mar 31, 2025 38.40%
Dec 31, 2024 34.61%
Sep 30, 2024 40.08%
Jun 30, 2024 38.29%
Mar 31, 2024 37.76%
Dec 31, 2023 33.66%
Sep 30, 2023 38.12%
Jun 30, 2023 39.59%
Mar 31, 2023 37.20%
Dec 31, 2022 35.69%
Sep 30, 2022 37.66%
Jun 30, 2022 37.13%
Mar 31, 2022 41.69%
Dec 31, 2021 32.64%
Sep 30, 2021 38.14%
Jun 30, 2021 38.19%